Evidence map›Paper›PMID 38791325›Full record

ArticleInternational journal of molecular sciences2024

Long-Term Epigenetic Regulation of

Eun-Hye Jang, Soon-Ae Kim

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eun-Hye JangDepartment of Pharmacology, School of Medicine, Eulji University, Daejeon 34824, Republic of Korea.
Soon-Ae KimDepartment of Pharmacology, School of Medicine, Eulji University, Daejeon 34824, Republic of Korea.ORCID 0000-0002-9831-0511

Funding

Eulji University 2023the National Research Foundation of Korea (NRF) grant funded by the Korean government, MIST No. 2020R1A2C1009499
6 · The paper itself

Abstract

Perinatal exposure to valproic acid is commonly used for autism spectrum disorder (ASD) animal model development. The inhibition of histone deacetylases by VPA has been proposed to induce epigenetic changes during neurodevelopment, but the specific alterations in genetic expression underlying ASD-like behavioral changes remain unclear. We used qPCR-based gene expression and epigenetics tools and Western blotting in the hippocampi of neonatal valproic acid-exposed animals at 4 weeks of age and conducted the social interaction test to detect behavioral changes. Significant alterations in gene expression were observed in males, particularly concerning mRNA expression of

Indexed as

Autism Spectrum DisorderEpigenesis, GeneticForkhead Box Protein O3HippocampusValproic AcidAnimalsAnimals, NewbornBehavior, AnimalDisease Models, AnimalDNA MethylationFemaleMalePregnancyPromoter Regions, GeneticRatsRats, Sprague-DawleyForkhead Box Protein O3FOXO3 protein, ratValproic AcidAscl1autism spectrum disorderepigeneticsFoxo3valproic acid

Identifiers

PMID38791325
PMCPMC11121443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.